| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-476-30 | 67877-476 | HUMAN PRESCRIPTION DRUG | Fingolimod | Fingolimod hydrochloride | CAPSULE | ORAL | 20220921 | N/A | ANDA | ANDA208004 | Ascend Laboratories, LLC | FINGOLIMOD HYDROCHLORIDE | .5 mg/1 | 30 CAPSULE in 1 BOTTLE (67877-476-30) |
| 67877-476-32 | 67877-476 | HUMAN PRESCRIPTION DRUG | Fingolimod | Fingolimod hydrochloride | CAPSULE | ORAL | 20220921 | N/A | ANDA | ANDA208004 | Ascend Laboratories, LLC | FINGOLIMOD HYDROCHLORIDE | .5 mg/1 | 7 BLISTER PACK in 1 CARTON (67877-476-32) / 7 CAPSULE in 1 BLISTER PACK |
| 67877-476-33 | 67877-476 | HUMAN PRESCRIPTION DRUG | Fingolimod | Fingolimod hydrochloride | CAPSULE | ORAL | 20220921 | N/A | ANDA | ANDA208004 | Ascend Laboratories, LLC | FINGOLIMOD HYDROCHLORIDE | .5 mg/1 | 10 BLISTER PACK in 1 CARTON (67877-476-33) / 10 CAPSULE in 1 BLISTER PACK |
| 67877-476-56 | 67877-476 | HUMAN PRESCRIPTION DRUG | Fingolimod | Fingolimod hydrochloride | CAPSULE | ORAL | 20220921 | N/A | ANDA | ANDA208004 | Ascend Laboratories, LLC | FINGOLIMOD HYDROCHLORIDE | .5 mg/1 | 28 CAPSULE in 1 BOTTLE (67877-476-56) |
| 67877-476-58 | 67877-476 | HUMAN PRESCRIPTION DRUG | Fingolimod | Fingolimod hydrochloride | CAPSULE | ORAL | 20220921 | N/A | ANDA | ANDA208004 | Ascend Laboratories, LLC | FINGOLIMOD HYDROCHLORIDE | .5 mg/1 | 28 BLISTER PACK in 1 CARTON (67877-476-58) / 14 CAPSULE in 1 BLISTER PACK (67877-476-14) |